Clinical Trial Update: MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating MiHA-loaded PD-L-silenced dendritic cell vaccination after allogeneic stem cell transplantation in hematological malignancies has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematological Malignancies

Drugs mentioned

• MiHA-loaded PD-L-silenced dendritic cell vaccination

Snippet

Sponsor: Radboud University Medical Center | Conditions: Hematological Malignancies | Phase 1, Phase 2 | Status: COMPLETED